Sunday, December 14, 2025 | 07:22 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Alembic Pharmaceuticals standalone net profit rises 29.63% in the September 2020 quarter

Image

Capital Market

Sales rise 23.36% to Rs 1400.01 crore

Net profit of Alembic Pharmaceuticals rose 29.63% to Rs 348.30 crore in the quarter ended September 2020 as against Rs 268.69 crore during the previous quarter ended September 2019. Sales rose 23.36% to Rs 1400.01 crore in the quarter ended September 2020 as against Rs 1134.90 crore during the previous quarter ended September 2019. ParticularsQuarter EndedSep. 2020Sep. 2019% Var.Sales1400.011134.90 23 OPM %32.5831.79 -PBDT456.66354.38 29 PBT419.95321.87 30 NP348.30268.69 30

Powered by Capital Market - Live News

 

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Oct 22 2020 | 5:07 PM IST

Explore News